Back to company

Afyx Development A/S: Financial statements 2018

CVR: 35839739

Afyx Development A/S (CVR 35839739) has filed annual accounts for 2018. In 2018, the company reported a gross profit of DKK -37,626,044 and a net result of DKK -45,055,310 compared with DKK -25,565,389 the year before. Equity amounted to DKK 54,231,523. The solvency ratio was 87.2%. The company had 8 employees in the financial year.

Gross Profit
-37,626,044 kr.
Profit/Loss
-45,055,310 kr.
Equity
54,231,523 kr.
Total Assets
62,161,030 kr.
Employees
8

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2018--37.6 mio.-45.1 mio.54.2 mio.8
2017--23.4 mio.-25.6 mio.99.3 mio.3
2016--10.1 mio.-9.3 mio.6.4 mio.1
2015--1.8 mio.-1.5 mio.11.6 mio.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Keep an eye on Afyx Development A/S

Get notified instantly about new financial statements, ownership changes, management changes and status changes.

Set up monitoring

Events in 2018

Jens Hansen leaves the board of Afyx Development A/SDec 21, 2018

As of December 21, 2018, Jens Hansen has left the board of directors of Afyx Development A/S.

Nishan de Silva joins Afyx Development A/S as adm. dir.Nov 19, 2018

As of November 19, 2018, Nishan de Silva is registered as adm. dir. of Afyx Development A/S.

Jens Hansen steps down as adm. dir. of Afyx Development A/SNov 19, 2018

As of November 19, 2018, Jens Hansen has stepped down as adm. dir. of Afyx Development A/S.

Afyx Development A/S: The 2017 annual report is outMay 18, 2018

Afyx Development A/S has published its annual report for 2017. Gross profit came to DKK -23,387,750, and the net result was DKK -25,565,389.

About Afyx Development A/S

Afyx Development A/S is a Danish company of the type Aktieselskab based in Hørsholm, founded in 2014. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Claus Juan Møller-San Pedro. The company is owned by Afyx Therapeutics A/S. The company has 8 employees. In 2025, the company reported a gross profit of DKK -5,044,782 and a net result of DKK -4,260,251 compared with DKK -6,896,490 the year before. Equity amounted to DKK -7,253,987.